vs

Side-by-side financial comparison of Infobird Co., Ltd (IFBD) and Scilex Holding Co (SCLX). Click either name above to swap in a different company.

Scilex Holding Co is the larger business by last-quarter revenue ($4.8M vs $3.4M, roughly 1.4× Infobird Co., Ltd). Infobird Co., Ltd runs the higher net margin — -46.7% vs -961.9%, a 915.2% gap on every dollar of revenue. On growth, Infobird Co., Ltd posted the faster year-over-year revenue change (17118.0% vs -67.8%).

Infobird Co., Ltd. is a China-based technology firm specializing in AI-powered customer engagement and smart customer service solutions. It serves clients across e-commerce, finance, telecommunications, and internet service sectors, offering cloud-based SaaS tools, intelligent call center systems, and customized digital operation support to help enterprises boost service efficiency and customer satisfaction.

Scilex Holding Co is a commercial-stage biopharmaceutical firm focused on developing and commercializing innovative non-opioid pain management therapies for acute and chronic pain segments. It primarily serves the US market, offering prescription and over-the-counter pain relief solutions for patients and healthcare providers.

IFBD vs SCLX — Head-to-Head

Bigger by revenue
SCLX
SCLX
1.4× larger
SCLX
$4.8M
$3.4M
IFBD
Growing faster (revenue YoY)
IFBD
IFBD
+17185.8% gap
IFBD
17118.0%
-67.8%
SCLX
Higher net margin
IFBD
IFBD
915.2% more per $
IFBD
-46.7%
-961.9%
SCLX

Income Statement — Q2 FY2025 vs Q4 FY2025

Metric
IFBD
IFBD
SCLX
SCLX
Revenue
$3.4M
$4.8M
Net Profit
$-1.6M
$-46.1M
Gross Margin
37.2%
45.5%
Operating Margin
-31.8%
-2317.8%
Net Margin
-46.7%
-961.9%
Revenue YoY
17118.0%
-67.8%
Net Profit YoY
-98.1%
-613.7%
EPS (diluted)
$-0.41
$-4.63

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IFBD
IFBD
SCLX
SCLX
Q4 25
$4.8M
Q3 25
$10.6M
Q2 25
$3.4M
$9.9M
Q1 25
$5.0M
Q4 24
$14.9M
Q3 24
$14.4M
Q2 24
$16.4M
Q1 24
$10.9M
Net Profit
IFBD
IFBD
SCLX
SCLX
Q4 25
$-46.1M
Q3 25
$-257.8M
Q2 25
$-1.6M
$-44.0M
Q1 25
$-26.1M
Q4 24
$-6.5M
Q3 24
$-4.4M
Q2 24
$-37.6M
Q1 24
$-24.4M
Gross Margin
IFBD
IFBD
SCLX
SCLX
Q4 25
45.5%
Q3 25
68.5%
Q2 25
37.2%
66.9%
Q1 25
72.3%
Q4 24
68.5%
Q3 24
73.9%
Q2 24
73.2%
Q1 24
64.7%
Operating Margin
IFBD
IFBD
SCLX
SCLX
Q4 25
-2317.8%
Q3 25
-1766.2%
Q2 25
-31.8%
-207.2%
Q1 25
-557.5%
Q4 24
-190.5%
Q3 24
-138.0%
Q2 24
-95.4%
Q1 24
-179.0%
Net Margin
IFBD
IFBD
SCLX
SCLX
Q4 25
-961.9%
Q3 25
-2441.5%
Q2 25
-46.7%
-445.1%
Q1 25
-521.2%
Q4 24
-43.4%
Q3 24
-30.4%
Q2 24
-229.6%
Q1 24
-224.0%
EPS (diluted)
IFBD
IFBD
SCLX
SCLX
Q4 25
$-4.63
Q3 25
$-22.17
Q2 25
$-0.41
$-7.42
Q1 25
$-2.26
Q4 24
$8.53
Q3 24
$-0.58
Q2 24
$-7.67
Q1 24
$-8.33

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IFBD
IFBD
SCLX
SCLX
Cash + ST InvestmentsLiquidity on hand
$698.0K
$5.0M
Total DebtLower is stronger
Stockholders' EquityBook value
$66.7M
$-207.8M
Total Assets
$72.4M
$365.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IFBD
IFBD
SCLX
SCLX
Q4 25
$5.0M
Q3 25
$878.0K
Q2 25
$698.0K
$4.1M
Q1 25
$5.8M
Q4 24
$3.3M
Q3 24
$77.0K
Q2 24
$6.9M
Q1 24
$1.8M
Stockholders' Equity
IFBD
IFBD
SCLX
SCLX
Q4 25
$-207.8M
Q3 25
$-176.9M
Q2 25
$66.7M
$-249.0M
Q1 25
$-211.5M
Q4 24
$-192.6M
Q3 24
$-211.3M
Q2 24
$-214.7M
Q1 24
$-189.8M
Total Assets
IFBD
IFBD
SCLX
SCLX
Q4 25
$365.0M
Q3 25
$275.9M
Q2 25
$72.4M
$83.8M
Q1 25
$79.0M
Q4 24
$93.0M
Q3 24
$100.4M
Q2 24
$104.5M
Q1 24
$91.2M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IFBD
IFBD
SCLX
SCLX
Operating Cash FlowLast quarter
$1.1M
$-17.5M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IFBD
IFBD
SCLX
SCLX
Q4 25
$-17.5M
Q3 25
$8.2M
Q2 25
$1.1M
$7.0M
Q1 25
$6.0M
Q4 24
$2.5M
Q3 24
$5.1M
Q2 24
$2.3M
Q1 24
$9.4M
Capex Intensity
IFBD
IFBD
SCLX
SCLX
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
0.0%
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons